In today’s briefing:
- Australian Clinical Labs (ACL AU) / Healius (HLS AU): Round 2?
Australian Clinical Labs (ACL AU) / Healius (HLS AU): Round 2?
- Reportedly, Australian Clinical Labs (ACL AU) and Healius (HLS AU) may reload a merger.
- The 2023 merger of the second and third-largest pathology plays was blocked by the ACCC. Any follow-up merger will similarly be blocked unless the combined entity jettisons certain ops.
- Since the collapse of the merger, Healius has sold its diagnostic business; Crescent Capital has exited ACL; and Capitol Health (CAJ AU) and Integral Diagnostics (IDX AU) merged.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Data and News
- ✓ Events & Webinars
